Cerus (CERS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cerus (CERS) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.00 of bullish evidence against -0.28 bearish.

Cerus last closed at $2.34, +2.63% on the session.

Against the IVW growth benchmark the position is +1.71% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

14 graded predictions for CERS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Cerus in the 31st percentile on return on equity, where 100 is best.

Cerus is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $459.48M.

StockMap tracks Cerus as the 76th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Cerus ranks 91st of 133 in the group, against a group median of -0.21.